ABBV Financials: AbbVie Inc AI Analysis

Home

Stock

ABBV

Financials

ABBV Financial

AbbVie Inc

$207.15

0.95%

$1.95

At close: Mar 25, 16:00:00 GMT-4

$206.55

-0.28%

$-0.59

Post-market: Mar 25, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

360

Report

Final Score

Key Stats

Prev.Close

$205.2

Open

$206.86

Day's Range

$205.85 - $209.68

52 week range

$164.39 - $244.81

Volume

3.9M

Avg.Volume

7.0M

Dividend yield

2.84%

EPS (TTM)

1.35

Market Cap

$365.0B

What is ABBV?

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 55,000 full-time employees. The company went IPO on 2013-01-02. The firm is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Its Immunology products include rheumatology, dermatology and gastroenterology. Its Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere, and Epkinly. The Company’s Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Its Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and Other eye care. Its Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its Venclexta is a B-cell lymphoma 2 (BCL-2) inhibitor used to treat blood cancers.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

ABBV Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	61,160	61,160	56,334	54,318	58,054	56,197
Revenue Growth (YoY)	9%	9%	4%	-6%	3%	23%
Cost of Revenue	17,357	17,357	16,904	18,226	16,527	17,314
Gross Profit	43,803	43,803	39,430	36,092	41,527	38,883
Selling, General & Admin	14,010	14,010	14,649	12,680	14,861	11,996
Research & Development	9,096	9,096	8,291	7,038	6,487	6,982
Operating Expenses	22,865	22,865	22,933	19,539	21,404	19,410
Other Non Operating Income (Expenses)	-5,793	-5,793	-3,240	-4,677	-2,448	-2,500
Pretax Income	6,597	6,597	3,716	6,250	13,477	12,989
Income Tax Expense	2,364	2,364	-570	1,377	1,632	1,440
Net Income	4,186	4,186	4,238	4,820	11,782	11,468
Net Income Growth	-1%	-1%	-12%	-59%	3%	152%
Shares Outstanding (Diluted)	1,776	1,773	1,773	1,773	1,778	1,777
Shares Change (YoY)	0%	0%	0%	0%	0%	6%
EPS (Diluted)	2.35	2.36	2.39	2.72	6.63	6.45
EPS Growth	-2%	-1%	-12%	-59%	3%	137%
Free Cash Flow	17,816	17,816	17,832	22,062	24,248	21,990
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	71.62%	71.62%	69.99%	66.44%	71.53%	69.19%
Operating Margin	34.23%	34.23%	29.28%	30.47%	34.66%	34.65%
Profit Margin	6.84%	6.84%	7.52%	8.87%	20.29%	20.4%
Free Cash Flow Margin	29.13%	29.13%	31.65%	40.61%	41.76%	39.13%
EBITDA	29,077	29,077	24,883	25,251	28,590	27,994
EBITDA Margin	47.54%	47.54%	44.17%	46.48%	49.24%	49.81%
D&A For EBITDA	8,139	8,139	8,386	8,698	8,467	8,521
EBIT	20,938	20,938	16,497	16,553	20,123	19,473
EBIT Margin	34.23%	34.23%	29.28%	30.47%	34.66%	34.65%
Effective Tax Rate	35.83%	35.83%	-15.33%	22.03%	12.1%	11.08%

Follow-Up Questions

What are AbbVie Inc's key financial statements?



According to the latest financial statement (Form-10K), AbbVie Inc has a total asset of $133,960, Net profit of $4,186

What are the key financial ratios for ABBV?



AbbVie Inc's Current ratio is 0.97, has a Net margin is 6.84, sales per share of $34.49.

How is AbbVie Inc's revenue broken down by segment or geography?



AbbVie Inc largest revenue segment is Immunology, at a revenue of 30,406,000,000 in the most earnings release.For geography, United States is the primary market for AbbVie Inc, at a revenue of 46,603,000,000.

Is AbbVie Inc profitable?



yes, according to the latest financial statements, AbbVie Inc has a net profit of $4,186

Does AbbVie Inc have any liabilities?



yes, AbbVie Inc has liability of 137,230

How many outstanding shares for AbbVie Inc?



AbbVie Inc has a total outstanding shares of 1,767.87

AbbVie Inc (ABBV) Financial

ABBV Stock Price Chart